Switch to:
NovaBay Pharmaceuticals Inc (AMEX:NBY)
Peter Lynch Fair Value
\$-33.94 (As of Today)

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. The growth rate we use is the average growth rate for earnings per share over the past 5 years. If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25. If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, NovaBay Pharmaceuticals Inc's PEG is 1. NovaBay Pharmaceuticals Inc's 5-Year EBITDA Growth Rate is 11.02. NovaBay Pharmaceuticals Inc's Earnings Per Share without Non-Recurring Items (NRI) for the trailing twelve months (TTM) ended in Sep. 2016 was \$-3.08. Therefore, the Peter Lynch Fair Value for today is \$-33.94.

As of today, NovaBay Pharmaceuticals Inc's share price is \$3.93. NovaBay Pharmaceuticals Inc's Peter Lynch fair value is \$-33.94. Therefore, NovaBay Pharmaceuticals Inc's Price to Peter Lynch Fair Value Ratio for today is N/A.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.

Definition

NovaBay Pharmaceuticals Inc's Peter Lynch Fair Value for today is calculated as

 Peter Lynch Fair Value = PEG * 5-Year EBITDA Growth Rate * Earnings Per Share (NRI) (TTM) = 1 * 11.02 * -3.08 = -33.94

NovaBay Pharmaceuticals Inc's Earnings Per Share (NRI) for the trailing twelve months (TTM) ended in Sep. 2016 was -1.14 (Dec. 2015 ) + -1.24 (Mar. 2016 ) + -0.36 (Jun. 2016 ) + -0.34 (Sep. 2016 ) = \$-3.08.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate. EBITDA growth is subject to less manipulations than net earnings per share. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.

Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. The growth rate we use is the average growth rate for earnings per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA over the past 5 years, which is 11.02 instead of 15 in this case.

NovaBay Pharmaceuticals Inc's Price to Peter Lynch Fair Value Ratio for today is calculated as

 Price to Peter Lynch Fair Value = Share Price / Peter Lynch Fair Value = 3.93 / -33.94 = N/A

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

NovaBay Pharmaceuticals Inc Annual Data

 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 lynchvalue N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

NovaBay Pharmaceuticals Inc Quarterly Data

 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 lynchvalue N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)